People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pathway Medical Technologies Inc | — | Biotechnology | Series A | $9.9M | $359.1M | 2010 |
Daniel Daniel Galles at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Daniel Galles on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Buckman | 1 | 10 |
| J. Daniel Cole | 1 | 7 |
| David Auth | 1 | 5 |
| Martien Daniel Van Osch | 1 | 1 |
| Michael Behlke | 1 | 1 |
| Avi Daniel Molcho | 1 | 1 |
| Ted Daniel Wulfman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.